Abstract
Introduction: Okur-Chung neurodevelopmental syndrome (OCNDS; #617062) has been associated with heterozygous mutations in the CSNK2A1 gene (*115440) mapped on the chromosome’s 20p13 region. Case Presentation: The analysis was performed on a 2-year-old patient who was admitted to our genetic diseases evaluation center by his family with a complaint of hypotonia. We detected a heterozygous NM_177559.3 (CSNK2A1):c.1139_1140dupGG (p.Met381GlyfsTer32) variant in the CSNK2A1 gene from a whole-exome sequence analysis. Conclusion: The variant that we detected has not been reported in open-access databases to date, so it was evaluated as a novel likely pathogenic variant according to the ACMG-2015 criteria. No variant was detected upon segregation analysis of the patient’s parents; therefore, the related variant was evaluated as de novo. In this study, we offer the first report of a pathogenic frameshift variant in the CSNK2A1 gene that has a relationship with OCNDS.
Journal Section:
Novel Insights from Clinical Practice
References
1.
Akahira-Azuma
M
, Tsurusaki
Y
, Enomoto
Y
, Mitsui
J
, Kurosawa
K
. Refining the clinical phenotype of Okur-Chung neurodevelopmental syndrome
. Hum Genome Var
. 2018
;5
:18011
.2.
Berman
HM
, Westbrook
J
, Feng
Z
, Gilliland
G
, Bhat
TN
, Weissig
H
et al. The protein Data Bank
. Nucleic Acids Res
. 2000
;28
(1
):235
–42
.3.
Burge
C
, Karlin
S
. Prediction of complete gene structures in human genomic DNA
. J Mol Biol
. 1997 Apr 25
268
1
78
94
.4.
Chiu
ATG
, Pei
SLC
, Mak
CCY
, Leung
GKC
, Yu
MHC
, Lee
SL
et al. Okur-Chung neurodevelopmental syndrome: eight additional cases with implications on phenotype and genotype expansion
. Clin Genet
. 2018
;93
(4
):880
–90
.5.
de Castro
E
, Sigrist
CJA
, Gattiker
A
, Bulliard
V
, Langendijk-Genevaux
PS
, Gasteiger
E
et al. ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins
. Nucleic Acids Res
. 2006
34
Web Server issue
W362
5
.6.
Hu
J
, Ng
PC
. SIFT Indel: predictions for the functional effects of amino acid insertions/deletions in proteins
. PLoS One
. 2013
;8
(10
):e77940
.7.
Keller
O
, Kollmar
M
, Stanke
M
, Waack
S
. A novel hybrid gene prediction method employing protein multiple sequence alignments
. Bioinformatics
. 2011
;27
(6
):757
–63
.8.
Lolli
G
, Pinna
LA
, Battistutta
R
. Structural determinants of protein kinase CK2 regulation by autoinhibitory polymerization
. ACS Chem Biol
. 2012
;7
(7
):1158
–63
.9.
Lolli
G
, Ranchio
A
, Battistutta
R
. Active form of the protein kinase CK2 α2β2 holoenzyme is a strong complex with symmetric architecture
. ACS Chem Biol
. 2014
;9
(2
):366
–71
.10.
Martinez-Monseny
A
, Casas-Alba
D
, Cesar
A
, Bolasell
M
, Casano
P
, Muchart
J
et al. Okur-Chung neurodevelopmental syndrome in a patient from Spain
. Am J Med Genet A
. 2020
;182
(1
):20
–4
.11.
Murakami
H
, Kuroda
Y
, Uehara
T
, Enomoto
Y
, Nishimura
N
, Kumaki
T
et al. Persistent hyperplastic primary vitreous with microphthalmia and coloboma in a patient with okur-chung neurodevelopmental syndrome
. Mol Syndromol
. 2022
;13
(1
):75
–9
.12.
Niefind
K
, Guerra
B
, Ermakowa
I
, Issinger
OG
. Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme
. EMBO J
. 2001
;20
(19
):5320
–31
.13.
Okur
V
, Cho
MT
, Henderson
L
, Retterer
K
, Schneider
M
, Sattler
S
et al. De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features
. Hum Gene
. 2016
;135
(7
):699
–705
.14.
Pettersen
EF
, Goddard
TD
, Huang
CC
, Couch
GS
, Greenblatt
DM
, Meng
EC
et al. UCSF Chimera: a visualization system for exploratory research and analysis
. J Comput Chem
. 2004
;25
(13
):1605
–12
.15.
Pietsch
M
, Viht
K
, Schnitzler
A
, Ekambaram
R
, Steinkrüger
M
, Enkvist
E
et al. Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2
. Bioorg Chem
. 2020
;96
:103608
.16.
Sayers
EW
, Beck
J
, Bolton
EE
, Bourexis
D
, Brister
JR
, Canese
K
et al. Database resources of the National Center for Biotechnology Information
. Nucleic Acids Res
. 2020
49
D1
D10
7
.17.
UniProt Consortium
. UniProt: the universal protein knowledgebase in 2021
. Nucleic Acids Res
. 2021
49
D1
D480
9
.18.
Trinh
J
, Huning
I
, Budler
N
, Hingst
V
, Lohmann
K
, Gillessen-Kaesbach
G
. A novel de novo mutation in CSNK2A1: reinforcing the link to neurodevelopmental abnormalities and dysmorphic features
. J Hum Gene
. 2017
;62
(11
):1005
–6
.19.
Varadi
M
, Anyango
S
, Deshpande
M
, Nair
S
, Natassia
C
, Yordanova
G
et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
. Nucleic Acids Res
. 2022
50
D1
D439
44
.20.
Waterhouse
A
, Bertoni
M
, Bienert
S
, Studer
G
, Tauriello
G
, Gumienny
R
et al. SWISS-MODEL: homology modelling of protein structures and complexes
. Nucleic Acids Res
. 2018
46
W1
W296
303
.21.
Werner
C
, Gast
A
, Lindenblatt
D
, Nickelsen
A
, Niefind
K
, Jose
J
et al. Structural and enzymological evidence for an altered substrate specificity in okur-chung neurodevelopmental syndrome mutant CK2αLys198Arg
. Fron Mol Biosci
. 2022
;9
:831693
.22.
Wu
RH
, Tang
W
, Qiu
KY
, Li
XJ
, Tang
DX
, Meng
Z
et al. Identification of novel CSNK2A1 variants and the genotype – phenotype relationship in patients with Okur–Chung neurodevelopmental syndrome: a case report and systematic literature review
. J Int Med Res
. 2021
;49
(5
):3000605211017063
.23.
Xu
S
, Lian
Q
, Wu
J
, Li
L
, Song
J
et al. Dual molecular diagnosis of tricho-rhino-phalangeal syndrome type I and Okur-Chung neurodevelopmental syndrome in one Chinese patient: a case report
. BMC Med Gene
. 2020
;21
(1
):158
.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.
